Case Studies from WellSpring Cancer Center
Mammosite Case Study
- Published: 08 June 2012
WELLSPRING ONCOLOGY OFFERS 5-DAY TARGETED MAMMOSITE RADIATION THERAPY
Women Get Back to Their Lives Sooner, Receiving Treatment in a More Personal and Caring Environment
According to the National Cancer Institute, it is estimated that 182,460 women were diagnosed with and 40,480 women died of breast cancer in 2008. In recent years, however, there has been a sudden increase in life-saving treatment advances against the disease. Doctors Franzese, Miller and Solc of WellSpring Oncology believe that their patients should have access to the latest innovative technologies available in the treatment of cancer and are pleased to offer:
MammoSite® 5-Day Targeted Radiation Therapy – The Most Widely Utilized Method of Partial Breast Irradiation
MammoSite Therapy is a breast-conserving treatment option for patients with early stage breast cancer. It can help women get through their cancer treatments and back to their normal lives sooner.
MammoSite 5-Day Targeted Radiation Therapy offers patients with early stage breast cancer the opportunity to complete their radiation treatment in just 5 days, as opposed to whole breast radiation therapy, which can take 6-to-7 weeks. With MammoSite Therapy, no longer do women need to juggle long-term work schedules, childcare and arrange for transportation to and from treatments.
MammoSite Therapy works by delivering radiation from within the lumpectomy cavity, directly to the tissue surrounding the cavity, where cancer is most likely to recur. Compared to the traditional 6-to-7 week external beam radiation therapy, MammoSite is a simpler, less-invasive method of delivering site-specific radiation treatment that is completed in only five days.
The new device delivers radiation directly to the area where a breast tumor was surgically removed via lumpectomy, the site where tumors most likely recur. With this specific approach, MammoSite avoids external beam therapy side effects such as the irradiation of healthy tissue.
5-Year Clinical Trial showed no local recurrences to date.
100% of patients would have MammoSite Therapy if they had to do it over again.
MammoSite 5-Day Targeted Radiation Therapy works from inside the breast, directly targeting the area where cancer is most likely to recur.